HIV-1 Gag cleavage site mutations and non-cleavage site mutations are closely related in viral fitness recovery process

被引：0
|
作者：
Myint, L
Matsuda, M
Matsuda, Z
Yokomaku, Y
Chiba, T
Okano, A
Yamada, K
Sugiura, W
机构：
[1] Natl Inst Infect Dis, AIDS Res Ctr, Tokyo, Japan
[2] St Marianna Univ, Sch Med, Inst Med Sci, Kawasaki, Kanagawa, Japan
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
77
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] The impact of Gag non-cleavage site mutations on HIV-1 viral fitness from integrative modelling and simulations
    Samsudin, Firdaus
    Gan, Samuel Ken-En
    Bond, Peter J.
    [J]. COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2021, 19 (19): : 330 - 342
  • [2] Gag non-cleavage site mutations contribute to full recovery of viral fitness in protease inhibitor-resistant human immunodeficiency virus type 1
    Myint, L
    Matsuda, M
    Matsuda, Z
    Yokomaku, Y
    Chiba, T
    Okano, A
    Yamada, K
    Sugiura, W
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (02) : 444 - 452
  • [3] Mutations in HIV-1 gag cleavage sites and their association with protease mutations
    Koch, N
    Yahi, N
    Fantini, J
    Tamalet, C
    [J]. AIDS, 2001, 15 (04) : 526 - 528
  • [4] Detection of HIV-1 GAG cleavage site mutations using the ViroSeq™ HIV-1 genotyping system and a new GAG genotyping module
    Petrauskene, OV
    Marlowe, NM
    MacLean, J
    Dileanis, JL
    Furtado, MR
    [J]. ANTIVIRAL THERAPY, 2002, 7 : S119 - S119
  • [5] New mechanism of HIV resistance: investigating cleavage site mutations in Gag
    Andersson, D.
    Van Maarseveen, N. M.
    Nijhuis, M.
    Konvalinka, J.
    [J]. FEBS JOURNAL, 2009, 276 : 298 - 298
  • [6] Positive Impact of HIV-1 gag Cleavage Site Mutations on the Virological Response to Darunavir Boosted with Ritonavir
    Larrouy, Lucile
    Lambert-Niclot, Sidonie
    Charpentier, Charlotte
    Fourati, Slim
    Visseaux, Benoit
    Soulie, Cathia
    Wirden, Marc
    Katlama, Christine
    Yeni, Patrick
    Brun-Vezinet, Francoise
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Descamps, Diane
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1754 - 1757
  • [7] Modeling the full length HIV-1 Gag polyprotein reveals the role of its p6 subunit in viral maturation and the effect of non-cleavage site mutations in protease drug resistance
    Su, Chinh Tran-To
    Kwoh, Chee-Keong
    Verma, Chandra Shekhar
    Gan, Samuel Ken-En
    [J]. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2018, 36 (16): : 4366 - 4377
  • [8] Relevance of HIV gag cleavage site mutations in failures of protease inhibitor therapies
    Verheyen, J.
    Altmann, A.
    Knops, E.
    Schuelter, E.
    Sichtig, N.
    Reuter, S.
    Faetkenheuer, G.
    Pfister, H.
    Kaiser, R.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A53 - A53
  • [9] HIV type 1 protease cleavage site mutations and viral fitness: Implications for drug susceptibility phenotyping assays
    Robinson, LH
    Myers, RE
    Snowden, BW
    Tisdale, M
    Blair, ED
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 2000, 16 (12) : 1149 - 1156
  • [10] Prevalence of HIV-1 GAG cleavage site mutations in patients failing protease inhibitors in the GART Study (CPCRA 046)
    Baxter, JD
    Leduc, R
    DuChene, A
    Leong, H
    Furtado, MR
    Petrauskene, OV
    [J]. ANTIVIRAL THERAPY, 2004, 9 (04) : U46 - U47
12345